Among TP53 wild-type (P53WT) solid tumors, MDM2 amplification has been demonstrated in well-differentiated and de-differentiated liposarcomas (WDLPS and DDLPS, respectively) and in glioblastoma multiforme (GBM) [5, 6]. This evidence concerns the gene MDM2 and glioblastoma.